Biondo Investment Advisors’s bluebird bio BLUE Stock Holding History

Biondo Investment Advisors’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-131	Closed	-$216K	–	87
2019 Q2	$216K	Hold	131	–	–	0.05%	85
2019 Q1	$267K	Buy	+131	New	+$231K	0.07%	78
2018 Q4	–	Sell	-131	Closed	-$247K	–	81
2018 Q3	$247K	Buy	131 +4	+3%	+$8.26K	0.06%	77
2018 Q2	$258K	Buy	127 +3	+2%	+$6.84K	0.07%	77
2018 Q1	$275K	Buy	124 +19	+18%	+$48.3K	0.07%	85
2017 Q4	$242K	Sell	105 -9	-8%	-$18.3K	0.06%	93
2017 Q3	$203K	Buy	+114	New	+$159K	0.06%	91

Other funds holding BLUE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Biondo Investment Advisors's BLUE Position: Q3 2019 in Review

Biondo Investment Advisors sold out of bluebird bio (BLUE) in Q3 2019, closing a stake of 131 shares — an estimated $216K sold.

Biondo Investment Advisors first reported a position in BLUE in Q3 2017 and held it in 7 quarters. The position peaked at $275K in Q1 2018. 241 funds tracked by Wall St. Rank hold BLUE as of Q3 2019.

Biondo Investment Advisors reported no remaining bluebird bio position as of Q3 2019 after selling out during the quarter.
Biondo Investment Advisors sold 131 bluebird bio shares in Q3 2019, an estimated $216K.
Biondo Investment Advisors first reported a position in bluebird bio in Q3 2017 and held it in 7 quarters.
Biondo Investment Advisors's bluebird bio position peaked at $275K in Q1 2018.
241 funds tracked by Wall St. Rank held bluebird bio as of Q3 2019.

Based on Biondo Investment Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.